Danpharmacy ApS: Financial statements 2022
CVR: 39361337
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Danpharmacy ApS (CVR 39361337) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -1,370 and a net result of DKK -19,124 compared with DKK -20,949 the year before. Equity in the 2022 report amounted to DKK 4,583. The solvency ratio was 4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -1,370
- Profit/Loss
- DKK -19,124
- Equity
- DKK 4,583
- Total Assets
- DKK 115,966
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -1K | -19K | 5K | 1 |
| 2021 | - | -3K | -21K | 24K | 1 |
| 2020 | - | -9K | -28K | 45K | 1 |
| 2019 | - | 37K | 28K | 73K | 1 |
| 2018 | - | 5K | -5K | 45K | 1 |
Official annual report
Keep an eye on Danpharmacy ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Danpharmacy ApS has published its annual report for 2021. Gross profit came to DKK -3,200, and the net result was DKK -20,949.
About Danpharmacy ApS
Danpharmacy ApS was a Danish company of the type Anpartsselskab based in Næstved, founded in 2018. The company has been dissolved on 24 June 2024. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. According to the 2022 annual report, the company had an average of 1 employee. In 2022, the company reported a gross profit of DKK -1,370 and a net result of DKK -19,124 compared with DKK -20,949 the year before. Equity in the 2022 report amounted to DKK 4,583.